Abstract

Boiogito (BO), a Japanese traditional herbal medicine, has been proven to be clinically effective against knee osteoarthritis (KOA)-associated pain. However, the therapeutic mechanism of BO remains unclear. Thus, we investigated the analgesic mechanism of BO using a rat KOA model. KOA was induced by destabilization of the medial meniscus (DMM). Rats were allocated into the following four groups: control, sham, DMM, and DMM + BO groups. Rotarod test was performed to evaluate the pain-related locomotive dysfunction. Expression of phosphorylated extracellular signal-regulated kinase1/2 (pERK1/2) in the spinal dorsal horn was examined using immunofluorescence staining and Western blotting on days 1 and 28 after DMM surgery. A mitogen-activated protein kinase inhibitor, U0126, was intrathecally injected and rotarod test and Western blotting were performed. The rotarod test revealed hampered locomotive function in the DMM group, which was significantly improved upon BO administration. The number of pERK1/2-positive cells was increased in the DMM group, whereas it was significantly decreased in the DMM + BO group. U0126 significantly inhibited ERK1/2 phosphorylation and increased walking time in the rotarod test, suggesting that the DMM-related pain was associated with ERK1/2 phosphorylation in the spinal dorsal horn. In conclusion, BO administration improved the pain-related locomotive dysfunction by suppressing ERK1/2 phosphorylation.

Highlights

  • Knee osteoarthritis (KOA) is a chronic joint disease that affects more than 300 million people worldwide and results in a limited range of motion and dysfunction of the knee joint with alteration in the alignment of the knee joint [1]

  • We examined the analgesic effect of BO on acute postoperative pain and osteoarthritisassociated pain as well as the involvement of ERK1/2 underlying the effect

  • This decrease was inhibited in the destabilization of the medial meniscus (DMM) + BO group (p < 0.05)

Read more

Summary

Introduction

Knee osteoarthritis (KOA) is a chronic joint disease that affects more than 300 million people worldwide and results in a limited range of motion and dysfunction of the knee joint with alteration in the alignment of the knee joint [1]. Surgical and nonsurgical treatments are available for KOA. Surgical treatments such as around knee osteotomy and total knee arthroplasty are performed for terminal KOA [1]. They are beneficial with excellent pain-relieving effects and functional recovery, they are not absolutely recommended for everyone due to their large physical and economic burden.

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call